phentermine has been researched along with Body Weight in 53 studies
Phentermine: A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Phentermine/topiramate has considerable benefit in reducing body weight, and the efficacy was closely related to the dosage." | 9.12 | Efficacy and Safety of Phentermine/Topiramate in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis. ( Lai, C; Lei, XG; Ruan, JQ; Sun, Z; Yang, X, 2021) |
| "Phentermine/topiramate combination therapy resulted in significant weight loss and improvements in cardiometabolic risk factors in patients with obesity/overweight in two published 56-week randomized, placebo-controlled trials (EQUIP and CONQUER)." | 7.83 | Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: What mediates improvement? ( Crosby, RD; Gadde, KM; Kolotkin, RL; Peterson, CA, 2016) |
| "To characterize the interactive effects of amylin with phentermine or sibutramine on food intake, body weight/composition and gene expression in diet-induced obese (DIO) rats." | 7.74 | Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats. ( Athanacio, J; Coffey, T; Kesty, NC; Lei, C; Mack, C; Parkes, DG; Roth, JD; Trevaskis, JL; Weyer, C; Wilson, J, 2008) |
| "The author treated 12 patients who had demonstrated only a minimal response to psychiatric treatment alone for their obesity with a combination of psychotherapy and an anorectic, phentermine resin." | 7.66 | Psychological treatment of obesity with phentermine resin as an adjunct. ( Roberts, CR, 1978) |
| " In the present experiments, we report: (1) the effects of acute administration of dexfenfluramine (DFEN) and PHEN individually and in combination on sweetened milk intake and body weight in non-deprived rats and (2) the effects of chronic administration (7 day minipump) of DFEN, PHEN, and their combination on daily food intake and body weight both during and after the treatment period." | 5.30 | Efficacy of administration of dexfenfluramine and phentermine, alone and in combination, on ingestive behavior and body weight in rats. ( Roth, JD; Rowland, NE, 1998) |
| "A 56-week randomized controlled trial was conducted to evaluate safety and efficacy of a controlled-release combination of phentermine and topiramate (PHEN/TPM CR) for weight loss (WL) and metabolic improvements." | 5.16 | Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). ( Allison, DB; Day, WW; Gadde, KM; Garvey, WT; Najarian, T; Peterson, CA; Schwiers, ML; Tam, PY; Troupin, B, 2012) |
| "In people with elevated blood pressure, orlistat, phentermine/topiramate and naltrexone/bupropion reduced body weight; the magnitude of the effect was greatest with phentermine/topiramate." | 5.12 | Long-term effects of weight-reducing drugs in people with hypertension. ( Berghold, A; Horvath, K; Jeitler, K; Krenn, C; Semlitsch, T; Siebenhofer, A; Winterholer, S, 2021) |
| "Phentermine/topiramate has considerable benefit in reducing body weight, and the efficacy was closely related to the dosage." | 5.12 | Efficacy and Safety of Phentermine/Topiramate in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis. ( Lai, C; Lei, XG; Ruan, JQ; Sun, Z; Yang, X, 2021) |
| "We studied platelet alpha-adrenergic receptor concentration and function in 19 subjects with simple obesity participating in a double-blind, controlled clinical trial of diet and anorexiants (phentermine, fenfluramine, or a combination of the two) or placebo." | 5.05 | Platelet alpha-adrenergic receptors in obesity: alteration with weight loss. ( Banerjee, SP; Hasday, JD; Hershey, LA; Kroening, BH; Sundaresan, PR; Weintraub, M, 1983) |
| "Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist, and phentermine, a psychostimulant structurally related to amphetamine, are drugs approved for the treatment of obesity and hyperphagia." | 3.91 | Determining the Effects of Combined Liraglutide and Phentermine on Metabolic Parameters, Blood Pressure, and Heart Rate in Lean and Obese Male Mice. ( Buch-Rasmussen, AS; Cowley, MA; Grove, KL; Kelly, LE; Koegler, FH; Pryor, JT; Simonds, SE, 2019) |
| " Patients receiving phentermine-topiramate had a greater proportion of weight loss after at least 20 weeks compared with those solely enrolled in the VA's MOVE! weight-management program." | 3.88 | Observational Comparative Effectiveness of Pharmaceutical Treatments for Obesity within the Veterans Health Administration. ( Grabarczyk, TR, 2018) |
| "Phentermine/topiramate combination therapy resulted in significant weight loss and improvements in cardiometabolic risk factors in patients with obesity/overweight in two published 56-week randomized, placebo-controlled trials (EQUIP and CONQUER)." | 3.83 | Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: What mediates improvement? ( Crosby, RD; Gadde, KM; Kolotkin, RL; Peterson, CA, 2016) |
| "To characterize the interactive effects of amylin with phentermine or sibutramine on food intake, body weight/composition and gene expression in diet-induced obese (DIO) rats." | 3.74 | Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats. ( Athanacio, J; Coffey, T; Kesty, NC; Lei, C; Mack, C; Parkes, DG; Roth, JD; Trevaskis, JL; Weyer, C; Wilson, J, 2008) |
| "This study evaluated the long-term efficacy and safety of the combination of phentermine and fenfluramine for the treatment of obesity in a private practice setting." | 3.69 | Long-term drug treatment of obesity in a private practice setting. ( Atkinson, RL; Blank, RC; Dhurandhar, NV; Ritch, DL; Schumacher, D, 1997) |
| "Fifty women with refractory obesity received phentermine resinate." | 3.66 | Plasma phentermine levels, weight loss and side-effects. ( Douglas, A; Douglas, JG; Munro, JF; Robertson, CE, 1983) |
| "The author treated 12 patients who had demonstrated only a minimal response to psychiatric treatment alone for their obesity with a combination of psychotherapy and an anorectic, phentermine resin." | 3.66 | Psychological treatment of obesity with phentermine resin as an adjunct. ( Roberts, CR, 1978) |
| "Chronic administration of chlorphentermine to rats resulted in a reduction of body weight compared to a normal control group." | 3.65 | Effect of chlorphentermine on the lipids of rat lungs. ( Gloster, J; Harris, P; Hasleton, P; Heath, D, 1976) |
| " Dosing changes were based on an algorithm that aimed to achieve 120% of ideal body weight (IBW) while minimizing adverse effects." | 2.67 | Long-term weight control study. III (weeks 104 to 156). An open-label study of dose adjustment of fenfluramine and phentermine. ( Moscucci, M; Schuster, B; Stein, EC; Sundaresan, PR; Weintraub, M, 1992) |
| " In some patients, weight regain may be prevented by giving the drug long term but the complications of long-term administration have yet to be evaluated." | 2.37 | The current status of antiobesity drugs. ( Farquhar, DL; Galloway, SM; Munro, JF, 1984) |
| " PHEN also significantly enhanced FEN's long-term toxic effects on 5-HT axons." | 1.30 | Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brain. ( McCann, UD; Ricaurte, GA; Yuan, J, 1998) |
| "Chlorphentermine HCl (CP) was used to induce preexisting alveolar alterations resembling a pulmonary lipidosis in mice to study these effects on the severity and duration of nitrogen dioxide (NO2) toxicity." | 1.27 | The effect of chlorphentermine pretreatment on the toxicity of nitrogen dioxide in mice. ( Born, GS; DeNicola, DB; Hastings, CE; Kessler, WV; Rebar, AH; Turek, JJ, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (52.83) | 18.7374 |
| 1990's | 12 (22.64) | 18.2507 |
| 2000's | 5 (9.43) | 29.6817 |
| 2010's | 6 (11.32) | 24.3611 |
| 2020's | 2 (3.77) | 2.80 |
| Authors | Studies |
|---|---|
| Siebenhofer, A | 1 |
| Winterholer, S | 1 |
| Jeitler, K | 1 |
| Horvath, K | 1 |
| Berghold, A | 1 |
| Krenn, C | 1 |
| Semlitsch, T | 1 |
| Lei, XG | 1 |
| Ruan, JQ | 1 |
| Lai, C | 1 |
| Sun, Z | 1 |
| Yang, X | 1 |
| Grabarczyk, TR | 1 |
| Simonds, SE | 1 |
| Pryor, JT | 1 |
| Koegler, FH | 1 |
| Buch-Rasmussen, AS | 1 |
| Kelly, LE | 1 |
| Grove, KL | 1 |
| Cowley, MA | 1 |
| Kelly, EM | 1 |
| Tungol, AA | 1 |
| Wesolowicz, LA | 1 |
| Kumar, RB | 1 |
| Aronne, LJ | 1 |
| Kolotkin, RL | 1 |
| Gadde, KM | 2 |
| Peterson, CA | 2 |
| Crosby, RD | 1 |
| Roth, JD | 2 |
| Trevaskis, JL | 1 |
| Wilson, J | 1 |
| Lei, C | 1 |
| Athanacio, J | 1 |
| Mack, C | 1 |
| Kesty, NC | 1 |
| Coffey, T | 1 |
| Weyer, C | 1 |
| Parkes, DG | 1 |
| Allison, DB | 1 |
| Garvey, WT | 1 |
| Schwiers, ML | 1 |
| Najarian, T | 1 |
| Tam, PY | 1 |
| Troupin, B | 1 |
| Day, WW | 1 |
| Wellman, PJ | 2 |
| Jones, SL | 1 |
| Miller, DK | 1 |
| WELSH, AL | 1 |
| EDE, M | 1 |
| RUBENKOENIG, HL | 1 |
| Frank, A | 1 |
| Ferrer-Lorente, R | 1 |
| Cabot, C | 1 |
| Fernández-López, JA | 1 |
| Remesar, X | 1 |
| Alemany, M | 1 |
| Kacew, S | 2 |
| Sundaresan, PR | 5 |
| Weintraub, M | 7 |
| Hershey, LA | 1 |
| Kroening, BH | 1 |
| Hasday, JD | 2 |
| Banerjee, SP | 1 |
| Mushlin, AI | 1 |
| Lockwood, DH | 1 |
| Galloway, SM | 1 |
| Farquhar, DL | 1 |
| Munro, JF | 2 |
| Douglas, A | 1 |
| Douglas, JG | 1 |
| Robertson, CE | 1 |
| Thoma-Laurie, D | 1 |
| Walker, ER | 1 |
| Reasor, MJ | 1 |
| Narbaitz, R | 1 |
| Ruddick, JA | 1 |
| Villeneuve, DC | 1 |
| Khan, M | 1 |
| Lum, CT | 1 |
| Rao, V | 1 |
| Cerda, JJ | 1 |
| Atkinson, RL | 1 |
| Blank, RC | 1 |
| Schumacher, D | 1 |
| Dhurandhar, NV | 1 |
| Ritch, DL | 1 |
| Halladay, AK | 1 |
| Fisher, H | 1 |
| Wagner, GC | 1 |
| Rowland, NE | 1 |
| McCann, UD | 1 |
| Yuan, J | 2 |
| Ricaurte, GA | 2 |
| Maher, TJ | 1 |
| Callahan, BT | 1 |
| Brightwell, DR | 1 |
| Naylor, CS | 1 |
| Hasleton, PS | 1 |
| Kay, JM | 1 |
| Heath, D | 2 |
| Roberts, CR | 1 |
| Gloster, J | 1 |
| Hasleton, P | 1 |
| Harris, P | 1 |
| András, K | 1 |
| Judith, G | 1 |
| Madan, M | 1 |
| Schuster, B | 4 |
| Balder, A | 1 |
| Lasagna, L | 1 |
| Cox, C | 2 |
| Moscucci, M | 1 |
| Stein, EC | 3 |
| Averbuch, M | 2 |
| Byrne, L | 2 |
| Camus, P | 1 |
| Joshi, UM | 1 |
| Lockard, VG | 1 |
| Petrini, MF | 1 |
| Lentz, DL | 1 |
| Mehendale, HM | 2 |
| Gibbs, HR | 1 |
| Silverstone, T | 1 |
| Hastings, CE | 1 |
| DeNicola, DB | 1 |
| Rebar, AH | 1 |
| Turek, JJ | 1 |
| Born, GS | 1 |
| Kessler, WV | 1 |
| Kutscher, CL | 1 |
| Gonmori, K | 1 |
| Morita, T | 1 |
| Papasava, M | 2 |
| Singer, G | 2 |
| Papasava, CL | 2 |
| Langlois, KJ | 1 |
| Forbes, JA | 1 |
| Bell, GW | 1 |
| Grant, GF | 1 |
| Court, JM | 1 |
| Truant, AP | 1 |
| Olon, LP | 1 |
| Cobb, S | 1 |
| Möllmann, H | 1 |
| Sowislo, W | 1 |
| Kindler, J | 1 |
| Malcolm, AD | 1 |
| Mace, PM | 1 |
| Outar, KP | 1 |
| Pawan, GL | 1 |
| Yelnosky, J | 2 |
| Panasevich, RE | 1 |
| Borrelli, AR | 1 |
| Lawlor, RB | 2 |
| Trivedi, MC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000506] | Phase 2 | 0 participants | Interventional | 1983-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for phentermine and Body Weight
| Article | Year |
|---|---|
Long-term effects of weight-reducing drugs in people with hypertension.
Topics: Adult; Anti-Obesity Agents; Appetite Depressants; Bias; Blood Pressure; Body Weight; Bupropion; Diet | 2021 |
Efficacy and Safety of Phentermine/Topiramate in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis.
Topics: Adult; Blood Pressure; Body Weight; Drug Therapy, Combination; Female; Fructose; Humans; Male; Middl | 2021 |
Formulary management of 2 new agents: lorcaserin and phentermine/topiramate for weight loss.
Topics: Adult; Anti-Obesity Agents; Appetite Depressants; Benzazepines; Body Weight; Clinical Trials, Phase | 2013 |
Efficacy comparison of medications approved for chronic weight management.
Topics: Adult; Anti-Obesity Agents; Appetite Depressants; Benzazepines; Body Weight; Clinical Trials as Topi | 2015 |
The current status of antiobesity drugs.
Topics: Adult; Amphetamine; Appetite Depressants; Body Weight; Child; Diethylpropion; Dose-Response Relation | 1984 |
Synergistic interactions between fenfluramine and phentermine.
Topics: Animals; Appetite; Appetite Depressants; Body Weight; Brain; Drug Synergism; Drug Therapy, Combinati | 1999 |
Clinical use of appetite suppressants.
Topics: Amphetamines; Appetite Depressants; Body Weight; Diethylpropion; Double-Blind Method; Drug Tolerance | 1986 |
The management of obesity.
Topics: Adolescent; Adult; Amphetamine; Body Weight; Child; Chlorphentermine; Diet, Reducing; Diethylpropion | 1972 |
11 trials available for phentermine and Body Weight
| Article | Year |
|---|---|
Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP).
Topics: Adolescent; Adult; Aged; Anti-Obesity Agents; Blood Glucose; Blood Pressure; Body Weight; Delayed-Ac | 2012 |
Platelet alpha-adrenergic receptors in obesity: alteration with weight loss.
Topics: Adult; Body Weight; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female | 1983 |
A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination.
Topics: Adolescent; Adult; Body Weight; Clinical Trials as Topic; Diet; Double-Blind Method; Drug Therapy, C | 1984 |
Effects of a combined behavioral and pharmacological program on weight loss.
Topics: Behavior Therapy; Body Weight; Female; Humans; Male; Obesity; Patient Dropouts; Phentermine; Placebo | 1979 |
Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo.
Topics: Adult; Behavior Therapy; Blood Pressure; Body Weight; Diet, Reducing; Double-Blind Method; Exercise; | 1992 |
Long-term weight control study. III (weeks 104 to 156). An open-label study of dose adjustment of fenfluramine and phentermine.
Topics: Adult; Blood Pressure; Body Weight; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fem | 1992 |
Long-term weight control study. IV (weeks 156 to 190). The second double-blind phase.
Topics: Adult; Behavior Therapy; Body Weight; Diet, Reducing; Double-Blind Method; Drug Therapy, Combination | 1992 |
Long-term weight control study. V (weeks 190 to 210). Follow-up of participants after cessation of medication.
Topics: Adult; Behavior Therapy; Body Weight; Diet, Reducing; Double-Blind Method; Drug Therapy, Combination | 1992 |
Long-term weight control study: conclusions.
Topics: Adult; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diet, Reducing; Drug Therapy, C | 1992 |
A double-blind clinical evaluation of the safety and efficacy of phentermine hydrochloride (Fastin) in the treatment of exogenous obesity.
Topics: Adult; Body Weight; Clinical Trials as Topic; Drug Tolerance; Female; Humans; Male; Middle Aged; Obe | 1974 |
Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study.
Topics: Adult; Age Factors; Appetite Depressants; Body Weight; Clinical Trials as Topic; Constipation; Diet, | 1972 |
34 other studies available for phentermine and Body Weight
| Article | Year |
|---|---|
Observational Comparative Effectiveness of Pharmaceutical Treatments for Obesity within the Veterans Health Administration.
Topics: Adult; Aged; Anti-Obesity Agents; Benzazepines; Body Weight; Cohort Studies; Delayed-Action Preparat | 2018 |
Determining the Effects of Combined Liraglutide and Phentermine on Metabolic Parameters, Blood Pressure, and Heart Rate in Lean and Obese Male Mice.
Topics: Animals; Anti-Obesity Agents; Blood Pressure; Body Weight; Drug Therapy, Combination; Heart Rate; Li | 2019 |
Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: What mediates improvement?
Topics: Adult; Body Mass Index; Body Weight; Depression; Female; Fructose; Health Status; Humans; Male; Midd | 2016 |
Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.
Topics: Amyloid; Animals; Anti-Obesity Agents; Body Composition; Body Weight; Cyclobutanes; Diet; Disease Mo | 2008 |
Effects of preexposure to dexfenfluramine, phentermine, dexfenfluramine-phentermine, or fluoxetine on sibutramine-induced hypophagia in the adult rat.
Topics: Animals; Antidepressive Agents, Second-Generation; Appetite Depressants; Body Weight; Cyclobutanes; | 2003 |
A study of the use of phenyl-tertiary-butylamine (Wilpo) to reduce weight.
Topics: Appetite; Body Weight; Body Weights and Measures; Butylamines; Obesity; Phenethylamines; Phentermine | 1961 |
The long-term management of obesity with continuing pharmacotherapy.
Topics: Adult; Aged; Appetite Depressants; Body Mass Index; Body Weight; Female; Humans; Male; Middle Aged; | 2004 |
Effects of oleoyl-estrone with dexfenfluramine, sibutramine or phentermine on overweight rats.
Topics: Animals; Anti-Obesity Agents; Body Weight; Cyclobutanes; Dexfenfluramine; Drug Interactions; Drug Th | 2005 |
Alterations in newborn and adult rat lung morphology and phospholipid levels after chlorcyclizine or chlorphentermine treatment.
Topics: Animals; Animals, Newborn; Body Weight; Chlorphentermine; Glycogen; Lung; Male; Organ Size; Phenterm | 1982 |
Plasma phentermine levels, weight loss and side-effects.
Topics: Adolescent; Adult; Aged; Appetite Depressants; Body Weight; Female; Humans; Ion Exchange Resins; Mid | 1983 |
Neonatal toxicity in rats following in utero exposure to chlorphentermine or phentermine.
Topics: Animals; Animals, Newborn; Body Weight; Chlorphentermine; Female; Lung; Lung Diseases; Maternal-Feta | 1982 |
Role of drug metabolism in protection against chlorphentermine-induced pulmonary phospholipidosis in adult rat.
Topics: Aminopyrine N-Demethylase; Aniline Hydroxylase; Animals; Body Weight; Chlorphentermine; Cytochrome P | 1981 |
Successful appetite suppression therapy with fenfluramine and phentermine in the obese diabetic transplant patient.
Topics: Blood Glucose; Body Weight; Diabetes Mellitus; Diabetic Nephropathies; Diet, Reducing; Drug Therapy, | 1995 |
The pharmacologic management of obesity.
Topics: Adult; Anti-Obesity Agents; Appetite Depressants; Body Mass Index; Body Weight; Chronic Disease; Fen | 1997 |
Long-term drug treatment of obesity in a private practice setting.
Topics: Adolescent; Adult; Appetite Depressants; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight | 1997 |
Interaction of phentermine plus fenfluramine: neurochemical and neurotoxic effects.
Topics: Adrenergic Agents; Animals; Body Weight; Brain; Central Nervous System Stimulants; Dopamine; Dopamin | 1998 |
Efficacy of administration of dexfenfluramine and phentermine, alone and in combination, on ingestive behavior and body weight in rats.
Topics: Animals; Appetite Depressants; Body Weight; Drug Synergism; Feeding Behavior; Fenfluramine; Male; Ph | 1998 |
Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Appetite Depressants; Biogenic Monoamines; Body Weight; Bra | 1998 |
Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermine.
Topics: Animals; Anorexia; Appetite Depressants; Biogenic Monoamines; Body Temperature; Body Weight; Brain; | 2000 |
Phentermine resinate and the pulmonary vasculature of the rat.
Topics: Animals; Blood Pressure; Body Weight; Heart; Hypertension, Pulmonary; Male; Organ Size; Phentermine; | 1977 |
Psychological treatment of obesity with phentermine resin as an adjunct.
Topics: Adolescent; Adult; Attitude to Health; Body Image; Body Weight; Evaluation Studies as Topic; Female; | 1978 |
Effect of chlorphentermine on the lipids of rat lungs.
Topics: Animals; Body Weight; Chlorphentermine; Chromatography, Gas; Chromatography, Liquid; Chromatography, | 1976 |
[Chronic administration of chlorphentermine (Desopimon)].
Topics: Body Weight; Chlorphentermine; Phentermine | 1976 |
Effects of drug-induced pulmonary phospholipidosis on lung mechanics in rats.
Topics: Animals; Body Weight; Chlorphentermine; Lung; Lung Compliance; Lung Volume Measurements; Male; Organ | 1989 |
Diet pills and sudden death.
Topics: Adult; Arrhythmias, Cardiac; Benzothiadiazines; Body Weight; Death, Sudden; Diuretics; Female; Human | 1988 |
The effect of chlorphentermine pretreatment on the toxicity of nitrogen dioxide in mice.
Topics: Animals; Body Weight; Cell Count; Chlorphentermine; Hyperplasia; Lipidoses; Lung; Macrophages; Male; | 1987 |
Action of fenfluramine, phenylpropanolamine, phentermine and diethylpropion on acoustic startle in rats.
Topics: Acoustic Stimulation; Animals; Appetite Depressants; Body Weight; Diethylpropion; Drug Tolerance; Fe | 1987 |
Effect of chlorphentermine on incorporation of [14C]choline in the rat lung phospholipids.
Topics: Animals; Body Weight; Carbon Radioisotopes; Chlorphentermine; Choline; Kinetics; Lung; Male; Organ S | 1986 |
Intravenous self-administration of phentermine in food-deprived rats: effects of abrupt refeeding and saline substitution.
Topics: Animals; Body Weight; Food Deprivation; Male; Phentermine; Rats; Rats, Inbred Strains; Reinforcement | 1986 |
Self-administration of phentermine by naive rats: effects of body weight and a food delivery schedule.
Topics: Animals; Body Weight; Food; Male; Phentermine; Rats; Rats, Inbred Strains; Reinforcement Schedule; S | 1985 |
[Influence of phentermine-resinate on the wall of pulmonary arteries (author's transl)].
Topics: Age Factors; Animals; Body Weight; Female; Male; Phentermine; Pulmonary Artery; Rats | 1974 |
Experimental evaluation of anorexigenic agents in man: a pilot study.
Topics: Adult; Appetite; Appetite Depressants; Body Weight; Diethylpropion; Fenfluramine; Humans; Male; Phen | 1972 |
Pharmacology of phentermine.
Topics: Amphetamine; Animals; Appetite; Appetite Depressants; Blood Pressure; Body Weight; Cardiovascular Sy | 1969 |
A determination of the anorexigenic potential of dl-amphetamine, d-amphetamine, l-amphetamine and phentermine.
Topics: Amphetamine; Animals; Appetite; Appetite Depressants; Body Weight; Dextroamphetamine; Drug Tolerance | 1969 |